Draft preBallot - This specification is under preBallot review and subject to change. It should not be used for implementation purposes. . . . . For a full list of available versions, see the Directory of published versions
PharmaceuticalBiologicProduceAndSubstanceCode
Link to ValueSet
This link will take you to this ValueSet on Simplifier.
SS-PharmaceuticalBiologicProductAndSubstanceCode-1-0-0
Canonical URL
https://fhir.infoway-inforoute.ca/ValueSet/pharmaceuticalbiologicproductandsubstancecode
Resource content
The views below provide an HTML rendered, XML and JSON look at this ValueSet:
ValueSet 'PharmaceuticalBiologicProductAndSubstanceCode'
Published by | Canada Health Infoway |
Status | Draft (since 2024-05-31) |
Experimental | False |
This subset is the combination of the PharmaceuticalBiologicProductCode and SubstanceCode subsets. This subset contains concepts that represent drug and vaccine products including generic names and tradenames, as well as concepts that represent general substances, the chemical constituents of pharmaceutical/biological products, body substances, dietary substances and diagnostic substances. This is a broad data exchange subset that is intended to support semantic interoperability and conformance testing. It is recommended that jurisdictions define and implement more specific clinically curated subsets that contain a portion of these concepts for data capture at the point of care for their specific use case. This subset was defined using the intensional definition of <373873005|Pharmaceutical / biologic product (product)| and <105590001|Substance (substance)| against the substrate SNOMED CT Canadian Edition. This resource is an informative value set; a normative subset containing the expanded values can be found on Canada Health Infoway's Terminology Server.
Contact Information
Website: http://www.infoway-inforoute.c...
Email: standards@infoway-inforoute.ca
This value set includes codes from the following code systems:
- Include codes from SNOMED_CT where concept DescendentOf 45931000087105
<ValueSet xmlns="http://hl7.org/fhir"> <id value="SS-PharmaceuticalBiologicProductAndSubstanceCode-1-0-0" /> <meta> <versionId value="1" /> <lastUpdated value="2024-07-11T15:39:47.513+00:00" /> <security> <system value="http://ontoserver.csiro.au/CodeSystem/ontoserver-permissions" /> <code value="restricted.read" /> </security> </meta> <url value="https://fhir.infoway-inforoute.ca/ValueSet/pharmaceuticalbiologicproductandsubstancecode" /> <identifier> <system value="urn:ietf:rfc:3986" /> <value value="urn:oid:2.16.840.1.113883.2.20.3.483" /> </identifier> <name value="PharmaceuticalBiologicProductAndSubstanceCode" /> <title value="PharmaceuticalBiologicProductAndSubstanceCode" /> <status value="draft" /> <experimental value="false" /> <date value="2024-05-31" /> <publisher value="Canada Health Infoway" /> <contact> <telecom> <system value="url" /> <value value="http://www.infoway-inforoute.ca" /> </telecom> <telecom> <system value="email" /> <value value="standards@infoway-inforoute.ca" /> </telecom> </contact> <description value="This subset is the combination of the PharmaceuticalBiologicProductCode and SubstanceCode subsets. This subset contains concepts that represent drug and vaccine products including generic names and tradenames, as well as concepts that represent general substances, the chemical constituents of pharmaceutical/biological products, body substances, dietary substances and diagnostic substances. This is a broad data exchange subset that is intended to support semantic interoperability and conformance testing. It is recommended that jurisdictions define and implement more specific clinically curated subsets that contain a portion of these concepts for data capture at the point of care for their specific use case. This subset was defined using the intensional definition of <373873005|Pharmaceutical / biologic product (product)| and <105590001|Substance (substance)| against the substrate SNOMED CT Canadian Edition. This resource is an informative value set; a normative subset containing the expanded values can be found on Canada Health Infoway's [Terminology Server](https://infocentral.infoway-inforoute.ca/en/tools/standards-tools/terminology-server)." /> <jurisdiction> <coding> <system value="urn:iso:std:iso:3166" /> <code value="CA" /> </coding> </jurisdiction> <copyright value="Copyright © 2025+ Canada Health Infoway. All rights reserved. [Terms of Use and License Agreements](https://ic.infoway-inforoute.ca/en/about/tou). [Privacy Policy](https://www.infoway-inforoute.ca/en/legal/privacy-policy)." /> <compose> <include> <system value="http://snomed.info/sct" /> <version value="http://snomed.info/sct/20611000087101" /> <filter> <property value="concept" /> <op value="descendent-of" /> <value value="45931000087105" /> </filter> </include> </compose> </ValueSet>
{ "resourceType": "ValueSet", "id": "SS-PharmaceuticalBiologicProductAndSubstanceCode-1-0-0", "meta": { "versionId": "1", "lastUpdated": "07/11/2024 15:39:47", "security": [ { "system": "http://ontoserver.csiro.au/CodeSystem/ontoserver-permissions", "code": "restricted.read" } ] }, "url": "https://fhir.infoway-inforoute.ca/ValueSet/pharmaceuticalbiologicproductandsubstancecode", "identifier": [ { "system": "urn:ietf:rfc:3986", "value": "urn:oid:2.16.840.1.113883.2.20.3.483" } ], "name": "PharmaceuticalBiologicProductAndSubstanceCode", "title": "PharmaceuticalBiologicProductAndSubstanceCode", "status": "draft", "experimental": false, "date": "2024-05-31", "publisher": "Canada Health Infoway", "contact": [ { "telecom": [ { "system": "url", "value": "http://www.infoway-inforoute.ca" }, { "system": "email", "value": "standards@infoway-inforoute.ca" } ] } ], "description": "This subset is the combination of the PharmaceuticalBiologicProductCode and SubstanceCode subsets. This subset contains concepts that represent drug and vaccine products including generic names and tradenames, as well as concepts that represent general substances, the chemical constituents of pharmaceutical/biological products, body substances, dietary substances and diagnostic substances. This is a broad data exchange subset that is intended to support semantic interoperability and conformance testing. It is recommended that jurisdictions define and implement more specific clinically curated subsets that contain a portion of these concepts for data capture at the point of care for their specific use case. This subset was defined using the intensional definition of <373873005|Pharmaceutical / biologic product (product)| and <105590001|Substance (substance)| against the substrate SNOMED CT Canadian Edition. This resource is an informative value set; a normative subset containing the expanded values can be found on Canada Health Infoway's [Terminology Server](https://infocentral.infoway-inforoute.ca/en/tools/standards-tools/terminology-server).", "jurisdiction": [ { "coding": [ { "system": "urn:iso:std:iso:3166", "code": "CA" } ] } ], "copyright": "Copyright © 2025+ Canada Health Infoway. All rights reserved. [Terms of Use and License Agreements](https://ic.infoway-inforoute.ca/en/about/tou). [Privacy Policy](https://www.infoway-inforoute.ca/en/legal/privacy-policy).", "compose": { "include": [ { "system": "http://snomed.info/sct", "version": "http://snomed.info/sct/20611000087101", "filter": [ { "property": "concept", "op": "descendent-of", "value": "45931000087105" } ] } ] } }